Adverse reactions: Top 10 suspect drugsDrugs most frequently cited in FDA reports. Editorial: Thanksgiving, in summerReminders about what's truly important in both life and work. 2011 State of the Industry Report: Ontario A status report on the issues affecting pharmacy right now. 2011 State of the Industry Report A status report on the issues affecting pharmacy right now. Drug News: July/August 2011 Abstral: SL opioid for breakthrough cancer pain and other new products. 2011 State of the Industry Report: The national view A status report on the issues affecting pharmacy right now. Editorial: Show us your winning ways We’re gearing up for awards season around here with our 2011 Commitment to Care & Service Awards open for nominations. 2011 State of the Industry Report: Manitoba A status report on the issues affecting pharmacy right now. Research Highlights: Short-course oral steroid in chronic rhinosinusitis with nasal polyps Trial evaluates combination of oral prednisolone, followed by fluticasone nasal drops and then fluticasone nasal spray. Do MRI before planning prostate cancer treatment Imaging accurately determines extent of disease to identify those suited to active surveillance First Previous 1432 1433 1434 1435 1436 Next Last
